14 citations
Counting papers with at most 25 authors, so collaboration author lists do not stand in for the people here.
- AstraZeneca (Switzerland)CH2 papers
- AstraZeneca (United Kingdom)GB2 papers
- AstraZeneca (Brazil)BR1 paper
- AstraZeneca (Poland)PL1 paper
- AstraZeneca (Spain)ES1 paper
- Berlin Institute for the Foundations of Learning and DataDE1 paper
- Graphcore (United Kingdom)GB1 paper
- Imperial College LondonGB1 paper
- King's College LondonGB1 paper
- King's College SchoolGB1 paper
- Nanjing Tech UniversityCN1 paper
- Technische Universität BerlinDE1 paper
7 papers
Adversarial Batch Representation Augmentation for Batch Correction in High-Content Cellular Screening
Lei Tong, Xujing Yao, Adam Corrigan +6
High-Content Screening routinely generates massive volumes of cell painting images for phenotypic profiling. However, technical variations across experimental executions inevitably…
Gradient-Guided Furthest Point Sampling for Robust Training Set Selection
Morris Trestman, Stefan Gugler, Felix A. Faber +1
Training set sampling methods are used to improve model performance and lower data costs in machine learning problems relevant to chemistry. We introduce Gradient Guided Furthest P…
Scalable Unit Harmonization in Medical Informatics via Bayesian-Optimized Retrieval and Transformer-Based Re-ranking
Jordi de la Torre
Objective: To develop and evaluate a scalable methodology for harmonizing inconsistent units in large-scale clinical datasets, addressing a key barrier to data interoperability. Ma…
The Role of Graph Topology in the Performance of Biomedical Knowledge Graph Completion Models
Alberto Cattaneo, Stephen Bonner, Thomas Martynec +4
Knowledge Graph Completion has been increasingly adopted as a useful method for helping address several tasks in biomedical research, such as drug repurposing or drug-target identi…
Potential outcome simulation for efficient head-to-head comparison of adaptive dose-finding designs
Michael Sweeting, Daniel Slade, Dan Jackson +1
Dose-finding trials are a key component of the drug development process and rely on a statistical design to help inform dosing decisions. Triallists wishing to choose a design requ…
Towards Robust Waveform-Based Acoustic Models
Dino Oglic, Zoran Cvetkovic, Peter Sollich +2
We study the problem of learning robust acoustic models in adverse environments, characterized by a significant mismatch between training and test conditions. This problem is of pa…
A Knowledge Graph-Enhanced Tensor Factorisation Model for Discovering Drug Targets
Cheng Ye, Rowan Swiers, Stephen Bonner +1
The drug discovery and development process is a long and expensive one, costing over 1 billion USD on average per drug and taking 10-15 years. To reduce the high levels of attritio…